| Aztreonam plus clavulanate, tazobactam, or avibactam for treatment of infections caused by metallo-β-lactamase-producing Gram-negative bacteria C Emeraud, L Escaut, A Boucly, N Fortineau, RA Bonnin, T Naas, L Dortet Antimicrobial agents and chemotherapy 63 (5), 10.1128/aac. 00010-19, 2019 | 125 | 2019 |
| Genetic diversity, biochemical properties, and detection methods of minor carbapenemases in Enterobacterales RA Bonnin, AB Jousset, C Emeraud, S Oueslati, L Dortet, T Naas Frontiers in Medicine 7, 616490, 2021 | 68 | 2021 |
| Comparison of disk diffusion, MIC test strip and broth microdilution methods for cefiderocol susceptibility testing on carbapenem-resistant Enterobacterales RA Bonnin, C Emeraud, AB Jousset, T Naas, L Dortet Clinical Microbiology and Infection 28 (8), 1156. e1-1156. e5, 2022 | 54 | 2022 |
| Using artificial intelligence to improve COVID-19 rapid diagnostic test result interpretation DA Mendels, L Dortet, C Emeraud, S Oueslati, D Girlich, JB Ronat, ... Proceedings of the National Academy of Sciences 118 (12), e2019893118, 2021 | 54 | 2021 |
| Emergence of new non–clonal group 258 high-risk clones among Klebsiella pneumoniae carbapenemase–producing K. pneumoniae isolates, France RA Bonnin, AB Jousset, A Chiarelli, C Emeraud, P Glaser, T Naas, ... Emerging Infectious Diseases 26 (6), 1212, 2020 | 46 | 2020 |
| Stability of routine biochemical analytes in whole blood and plasma from lithium heparin gel tubes during 6‐hr storage D Monneret, A Godmer, R Le Guen, C Bravetti, C Emeraud, A Marteau, ... Journal of Clinical Laboratory Analysis 30 (5), 602-609, 2016 | 41 | 2016 |
| Uncovering the novel Enterobacter cloacae complex species responsible for septic shock deaths in newborns: a cohort study D Girlich, S Ouzani, C Emeraud, L Gauthier, RA Bonnin, N Le Sache, ... The Lancet Microbe 2 (10), e536-e544, 2021 | 34 | 2021 |
| Outbreak of CTX-M-15 Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae ST394 in a French Intensive Care Unit Dedicated to COVID-19 C Emeraud, S Figueiredo, RA Bonnin, M Khecharem, S Ouzani, ... Pathogens 10 (11), 1426, 2021 | 28 | 2021 |
| Evaluating 10 commercially available SARS-CoV-2 rapid serological tests by use of the STARD (Standards for Reporting of Diagnostic Accuracy Studies) method L Dortet, JB Ronat, C Vauloup-Fellous, C Langendorf, DA Mendels, ... Journal of clinical microbiology 59 (2), 10.1128/jcm. 02342-20, 2021 | 27 | 2021 |
| Screening of OXA-244 producers, a difficult-to-detect and emerging OXA-48 variant? C Emeraud, L Biez, D Girlich, AB Jousset, T Naas, RA Bonnin, L Dortet Journal of Antimicrobial Chemotherapy 75 (8), 2120-2123, 2020 | 27 | 2020 |
| Evaluation of the immunochromatographic NG-Test Carba 5 for rapid identification of carbapenemase in nonfermenters A Potron, D Fournier, C Emeraud, P Triponney, P Plésiat, T Naas, L Dortet Antimicrobial Agents and Chemotherapy 63 (9), 10.1128/aac. 00968-19, 2019 | 26 | 2019 |
| Emergence and Polyclonal Dissemination of OXA-244–Producing Escherichia coli, France C Emeraud, D Girlich, RA Bonnin, AB Jousset, T Naas, L Dortet Emerging Infectious Diseases 27 (4), 1206, 2021 | 25 | 2021 |
| Emergence of VIM-producing Enterobacter cloacae complex in France between 2015 and 2018 C Emeraud, C Petit, L Gauthier, RA Bonnin, T Naas, L Dortet Journal of Antimicrobial Chemotherapy 77 (4), 944-951, 2022 | 18 | 2022 |
| Rapid Determination of SARS-CoV-2 antibodies using a bedside, point-of-Care, serological test L Dortet, C Emeraud, C Vauloup-Fellous, M Khecharem, JB Ronat, ... Emerging Microbes & Infections 9 (1), 2212-2221, 2020 | 18 | 2020 |
| Susceptibility of OXA-48-producing Enterobacterales to imipenem/relebactam, meropenem/vaborbactam and ceftazidime/avibactam RA Bonnin, S Bernabeu, C Emeraud, E Creton, O Vanparis, T Naas, ... International Journal of Antimicrobial Agents 60 (4), 106660, 2022 | 16 | 2022 |
| KPC-39-mediated resistance to ceftazidime-avibactam in a Klebsiella pneumoniae ST307 clinical isolate AB Jousset, S Oueslati, C Emeraud, RA Bonnin, L Dortet, BI Iorga, T Naas Antimicrobial agents and chemotherapy 65 (12), 10.1128/aac. 01160-21, 2021 | 16 | 2021 |
| Polyclonal Dissemination of OXA-232 Carbapenemase–Producing Klebsiella pneumoniae, France, 2013–2021 C Emeraud, A Birer, D Girlich, AB Jousset, E Creton, T Naas, RA Bonnin, ... Emerging Infectious Diseases 28 (11), 2304, 2022 | 15 | 2022 |
| Caractéristiques et évolution des souches d’entérobactéries productrices de carbapénémases (EPC) isolées en France, 2012–2020 AB Jousset, C Emeraud, RA Bonnin, T Naas, L Dortet Bull Epidémiol Hebd 18 (19), 351-8, 2021 | 15 | 2021 |
| In vitro activity of imipenem-relebactam, meropenem-vaborbactam, ceftazidime-avibactam and comparators on carbapenem-resistant non-carbapenemase-producing enterobacterales RA Bonnin, S Bernabeu, C Emeraud, T Naas, D Girlich, AB Jousset, ... Antibiotics 12 (1), 102, 2023 | 14 | 2023 |
| Activity of mecillinam against carbapenem-resistant Enterobacterales C Emeraud, A Godmer, D Girlich, O Vanparis, F Mahamdi, E Creton, ... Journal of Antimicrobial Chemotherapy 77 (10), 2835-2839, 2022 | 14 | 2022 |
